Shandong Xinde Technology Co., Ltd., founded in 1999, is a well-known trademark in Shandong Province, a high-tech enterprise group integrating R&D, production and sales of biological products/biochemical pharmaceuticals/veterinary drug preparations/feed additives and veterinary drug APIs
Zhucheng Xinde Pharmaceutical Co., Ltd., the predecessor of Shandong Xinde Technology Co., Ltd., was established in April 1999, since its establishment, the company has always adhered to the core concept of "unswervingly increasing customer value", and has achieved sustained, rapid and healthy development. Now it has developed into a national high-tech enterprise group integrating R&D, production and sales.
At present, it has five product lines of biological products, biochemical pharmaceuticals, veterinary drug preparations, feed additives and veterinary drug APIs, and the group is composed of Shandong Xinde Technology Co., Ltd., Shandong Xinde Animal Vaccine Co., Ltd., Qingdao Xinde Pharmaceutical Co., Ltd., Sichuan Huaxi Animal Pharmaceutical Co., Ltd., and Beijing Xindewei Technology Co., Ltd.
The Group has four production bases, among which Xinde Biological Industrial Park, located in Zhucheng Development Zone, has two biochemical pharmaceutical workshops, three veterinary drug preparation workshops, one API synthesis workshop, one traditional Chinese medicine extraction and extraction workshop, one biological enzyme fermentation workshop and corresponding supporting facilities; Beijing Xinde Biological Products Factory has six production lines and is the most complete veterinary biological products factory in China. The factory of Shandong Xinde Vaccine Co., Ltd. mainly produces highly pathogenic avian influenza vaccine, and is the only factory in China that uses cell suspension culture process to produce avian influenza vaccine. Sichuan Huaxi factory is mainly engaged in the production of pig medicine, with multiple production lines such as water injection, powder injection, oral liquid, and traditional Chinese medicine.
The Group has two technology centers, of which Qingdao Technology Center has been recognized as a key technology center by Shandong Provincial Government; It also has three P2 laboratories and three nationally certified animal houses; P3 Lab is under construction.
The group's R&D team has more than 100 doctors and masters, in addition to strengthening its own R&D team building, the company has joined forces with China Agricultural University, Chinese Academy of Agricultural Sciences, China Institute of Veterinary Drug Supervision, Harbin Veterinary Research Institute, South China Agricultural University, Qingdao Agricultural University and a number of veterinary drug enterprises to establish the China Animal Health Industry R&D and Innovation Alliance chaired by Xinde Group, established a larger technological innovation platform, and has carried out more than 30 technical cooperations; The group has also established long-term cooperative relations with international animal protection companies and research institutions such as Australian Bioresources Company, French Vik Company, Taiwan Animal Vaccine Research Institute, etc.
In addition to investing a lot of resources in the development of new products, the group has also invested huge manpower and material resources in the research of animal disease control, and the group technology center has set up two laboratories for pig disease and poultry disease, and conducts pathogen separation and analysis of disease materials from all over the country every day; Integrate the national animal epidemic to design disease control programs, and conduct a large number of clinical trials to screen the best programs; The group has also established a long-term cooperative relationship with Professor Zhao Jixun and his research team at China Agricultural University to track the mutations of various infectious diseases and modify vaccine strains in a timely manner.
The group has set up eight business departments according to the service target customers, and has realized the specialization of technical services. The eight business departments are poultry business department, livestock business department, imported vaccine business department, self-produced vaccine business department, national compulsory immunization products business department, feed additives business department, API business department, and international business department.
The company has always taken the provision of disease control programs for the aquaculture industry as an important means of technical service support, and also provides technical training, management consulting and other service support for partners to help partners become bigger and stronger. Due to the continuous insistence on creating value for customers, Xinde's brand has been recognized by customers in the aquaculture industry, and the "Xinde" brand has been recognized as well-known protection, and Xinde is the first enterprise in the animal protection industry to receive this honor.
As an enterprise with a sense of social responsibility, Xinde has donated millions of yuan to social welfare undertakings such as the Hope Project and earthquake relief.
In the future, Xinde Technology will continue to rely on strong R&D strength, innovate closely around customer needs, provide more and more effective series of products and professional technical services for breeding enterprise groups and farmers, and lead the healthy development of the industry.
